NEW: STA®-Liatest® D-Di Plus, Less interferences for even More Confidence
As part of Stago's continuous improvement commitment, STA® -Liatest® D-Di Plus* was developed as an evolution of the STA® -Liatest® D-Di, on...
STA Compact Max®: Innovation born from Expertise
STA Compact Max® is the new generation of analyser developed by the Coagulation Company to meet labs' expectations.
STA®-Rivaroxaban Calibrator & STA®-Rivaroxaban Control (CE marked)
Rivaroxaban is a new oral anticoagulant, direct factor Xa inhibitor, developed by Bayer HealthCare and sold under the trade name Xarelto®. ...
For every Heparin Induced Thrombocytopenia (HIT) suspicion. A rapid and specific exclusion of Heparin Induced Thrombocytopenia in 10 minute...
This innovating test is an indirect marker of Tissue Factor exposure In Vivo.
Diagnostica Stago, the worldwide leader in the field of Haemostasis is setting the standard of excellence, with cutting-edge technologies, products and customer service. United Kingdom is one of the countries where research is the most advanced in the field of coagulation and the demand for new technologies is great. In January 2005, the subsidiary Diagnostica Stago UK was opened.
Stago’s first mission is to provide health professionals with reliable, powerful and innovative haemostasis diagnostic tools in looking for a way to improve prevention, understanding, diagnostic, treatment and follow-up of coagulation-related pathologies.
April 15th - 17th, 2013
June 29th - July 4th, 2013
September 3rd - 4th, 2013
This 
free educational application in English is the first of its kind and has been developed by an expert in Haemostasis… Stago.
Did you know?
Von Willebrand had first described in 1926 a haemorrhagic familial syndrome, inherited in a dominant manner, in a small ethnic group of Aaland islands, located in the Baltic sea, between Sweden and Finland.
Recent Jobs
We don't have any job openings at the moment. Please check back later.
Apply
